You are here: Industry Insights > Financing

News List

Transcenta Closes $105 Million in Crossover Financing prnasia
December 23, 2020
Transcenta Holding Limited, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces today the completion of a 105 million USD crossover financing.
Three big-ticket deals contributed 69 per cent of total deal value in November 2020 expresspharma
December 07, 2020
In November 2020, the healthcare industry reported 58 deals worth $13.5 billion as compared to the last 12-month average (November 2019 to October 2020) of 81 deals worth $14.5 billion.
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital prnasia
September 27, 2020
ImmVira Group Company, a biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics today announced signing of US$10 million Series B Plus strategic financing.
Recursion raises $239m and signs drug discovery deal with Bayer pharmaceutical-technology
September 24, 2020
Digital biology company Recursion Pharmaceuticals has secured $239m in a Series D financing round led by Leaps by Bayer, the impact investment arm of Bayer.
Casma Therapeutics raises $50m to support muscular dystrophy pharmaceutical-technology
September 14, 2020
US-based biotechnology company Casma Therapeutics has secured $50m in a Series B financing round to support the development of a programme targeting muscular dystrophy treatment.
F2G raises $60.8m to support late-stage antifungal clinical programme pharmatimes
August 14, 2020
UK-Austria-based biotech F2G has secured $60.8m in a new financing round to support late-stage development of a novel antifungal agent.
TFF Pharmaceuticals Secures $25.9 Million contractpharma
August 12, 2020
TFF Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform, has entered into a definitive agreement with ...
Triplet Therapeutics Launches with $59 Million in Financing to Further its Development of Transformative Treatments for Triplet Repeat Disorders firstwordpharma
December 17, 2019
Atlas Venture, which co-founded and seeded Triplet with a $10 million investment, also participated in the Series A alongside Invus, Partners Innovation Fund and Alexandria Venture Investments.
TBI-focused vasopharm closes a €9.5m financing round pharmaceutical-technology
July 12, 2019
German pharma company vasopharm has announced it has closed a €9.5m financing round, which was co-led by HeidelbergCapital Private Equity and EF Investments.
BlackStone Therapeutics closes $76 m Series B financing biospectrumasia
June 16, 2019
BlackThorn also announced two appointments to its executive management team: Jane Tiller, MBChB, FRCPsych, as chief medical officer, and Laura Hansen, Ph.D., as vice president, corporate affairs. Dr. Tiller, who brings extensive clinical psychiatry and dr

Previous page 1 2 3 4 5 6 7 Next page